Media Coverage

By clicking the media coverage links below, you will be leaving the Lantern Pharma Inc. website. The information reached through the links below is separate from the Lantern Pharma Inc. website and is not maintained by Lantern Pharma Inc.

Jul 6, 2020

5 Dallas Biotech Companies Turning the Lone Star State into a Life Sciences Leader

Jun 18, 2020

Biotech startup Lantern Pharma’s IPO yields $26 million for its cancer drug development

Apr 16, 2020

Dallas biotech company files to go public as it works to help beat cancer

Feb 1, 2020

Artificial Intelligence – How the Race to Create a True Thinking Machine Will Reshape Business

Dec 19, 2019

AI Makes Inroads in Life Sciences in Small but Significant Ways: Lantern Pharma’s quest

Dec 13, 2019

Where are the Opportunities for Medtech and Pharma in 2020?

Dec 10, 2019

Can this AI platform Change the Future of Cancer Treatments?

Oct 12, 2019

Lantern Pharma – How Technology is Fighting Against Cancer

Oct 3, 2019

Lantern Pharma Partners with NCI to Aid Precision Oncology Research Treatments

Aug 30, 2019